Immune thrombocytopenia successfully treated with eltrombopag following multiple therapies including romiplostim

被引：6
|
作者：
Sartori, Roberto [1 ,2 ]
Candiotto, Laura [1 ,2 ]
Ruggeri, Marco [3 ]
Tagariello, Giuseppe [1 ,2 ]
机构：
[1] Castelfranco Veneto Hosp, Haemophilia Ctr, Transfus Serv, I-31033 Castelfranco Veneto, TV, Italy
[2] Castelfranco Veneto Hosp, Dept Haematol, I-31033 Castelfranco Veneto, TV, Italy
[3] San Bortolo Hosp, Dept Cell Therapy & Haematol, Vicenza, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷
关键词：
D O I：
10.2450/2013.0135-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S151 / S152
页数：2
相关论文
共 50 条
  • [31] Cost-minimization analysis comparing eltrombopag vs romiplostim for adults with chronic immune thrombocytopenia
    Patwardhan, Pallavi
    Proudman, David
    Allen, Jeffrey
    Lucas, Sedge
    Nellesen, Dave
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (10): : 1447 - 1456
  • [32] Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
    Nam, Chang Hyun
    Byun, Ja Min
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD RESEARCH, 2021, 56 (03) : 202 - 204
  • [33] Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
    Hanny Al-Samkari
    Elizabeth M. Van Cott
    David J. Kuter
    Annals of Hematology, 2019, 98 : 581 - 588
  • [34] Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
    Al-Samkari, Hanny
    Van Cott, Elizabeth M.
    Kuter, David J.
    ANNALS OF HEMATOLOGY, 2019, 98 (03) : 581 - 588
  • [35] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    David J. Kuter
    Cynthia Macahilig
    Kelly M. Grotzinger
    Sara A. Poston
    Peter Feng Wang
    Katie L. Dawson
    Melea Ward
    International Journal of Hematology, 2015, 101 : 255 - 263
  • [36] ITP SUCCESSFUL TREATMENT WITH ELTROMBOPAG FOLLOWING MULTI-THERAPY FAILURE (INCLUDING ROMIPLOSTIM)
    Tagariello, G.
    Sartori, R.
    Radossi, P.
    Maschio, N.
    Scarpa, E.
    Tassinari, C.
    HAEMATOLOGICA, 2012, 97 : 685 - 685
  • [37] Predictive factors of response to eltrombopag and romiplostim in Egyptian immune thrombocytopenia patients: a single center experience
    El Demerdash, Doaa
    Mohamady, Nagham
    Abdelghany, Wafaa
    Youssef, Heba
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (01): : 88 - 93
  • [38] ECONOMIC EVALUATION OF ROMIPLOSTIM VS ELTROMBOPAG IN THE TREATMENT OF ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA IN MEXICO
    Naranjo, M.
    Alva, M. E.
    Carlos, F.
    VALUE IN HEALTH, 2017, 20 (09) : A893 - A893
  • [39] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    Kuter, David J.
    Macahilig, Cynthia
    Grotzinger, Kelly M.
    Poston, Sara A.
    Wang, Peter Feng
    Dawson, Katie L.
    Ward, Melea
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 255 - 263
  • [40] Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - A case report
    Cruz Freitas Ferreira, Iolanda Joao Mora
    Sousa, Filipa
    Vasco, Elsa Marques
    Fialho de Amaral Areia, Ana Luisa
    Achando Silva Moura, Jose Paulo
    Carda, Jose
    Ribeiro, Leticia
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (08) : 405 - 408
12345